Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, December 6 2016 5:09pm ET - U.S. Markets Closed.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Biotechnology News
Latest News
Tuesday, Dec 6, 2016
·Mast Therapeutics Announces Initiation Of Patient Enrollment In Additional Phase 2 Study Of AIR001 For The Treatment Of Heart Failure With Preserved Ejection Fraction
PR Newswire - 9 minutes ago
·Calithera Biosciences Reports CB-839 Phase I Triple Negative Breast Cancer Combination Data at the 2016 San Antonio Breast Cancer Symposium
GlobeNewswire - 9 minutes ago
·Agios Falls on Safety Concerns (AGIO)
at Investopedia - 14 minutes ago
·VBI Vaccines Closes $23.6 Million Financing from Perceptive Advisors
Marketwire - 39 minutes ago
·Theravance Biopharma Receives FDA Fast Track Designation for Velusetrag (TD-5108) for Idiopathic and Diabetic Gastroparesis
PR Newswire - 39 minutes ago
·Sage jumps 8% on expedited development plan for postpartum depression treatment
at MarketWatch - 48 minutes ago
·Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results
GlobeNewswire - 49 minutes ago
·What's behind put volume in Acadia
optionMONSTER - 53 minutes ago
·XBiotech Completes Enrollment in Global Phase I/II Study for its True Human(TM) Antibody Treatment for Serious Staphylococcus aureus Infections
Thomson Reuters ONE - 1 hour, 7 minutes ago
·BioPharmX to Report Third Quarter Financial Results
PR Newswire - 1 hour, 9 minutes ago
·Inovio MERS Vaccine Development to be Expanded with Funding from International Vaccine Institute
GlobeNewswire - 1 hour, 9 minutes ago
·CymaBay Therapeutics Announces that the Recommended International Nonproprietary Name for MBX-8025 is Seladelpar
GlobeNewswire - 1 hour, 9 minutes ago
·XBiotech Completes Enrollment in Global Phase I/II Study for its True Human™ Antibody Treatment for Serious Staphylococcus aureus Infections
GlobeNewswire - 1 hour, 9 minutes ago
·Premier Biomedicals Research on its Patent Pending Anti-Cancer Treatment With Metronomic Chemotherapy Recognized for Publication in the Prestigious British Journal of Cancer
Marketwire - 1 hour, 9 minutes ago
·ARIAD Announces Data Presentations at American Society of Hematology Meeting
Business Wire - 1 hour, 34 minutes ago
·TG Therapeutics, Inc. Announces Double & Triple Combination Therapy Data Presentations at the 58th American Society of Hematology Annual Meeting
GlobeNewswire - 1 hour, 39 minutes ago
·Auris Medical on Track to Resume Enrollment of Keyzilen Tinnitus Program Following Regulatory Feedback
GlobeNewswire - 2 hours, 5 minutes ago
·Onconova and Cellworks Announce Presentation of Rigosertib Predictive Signature for Clinical Response in Myelodysplastic Syndromes (MDS) at 2016 ASH Annual Meeting
GlobeNewswire - 2 hours, 8 minutes ago
·Auris Medical on Track to Resume Enrollment of Keyzilen™ Tinnitus Program Following Regulatory Feedback
GlobeNewswire - 2 hours, 9 minutes ago
·TG Therapeutics, Inc. Announces that the GENUINE Phase 3 Study has Reached Target Enrollment
GlobeNewswire - 2 hours, 9 minutes ago
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?